Intel’s pharmaceutical branch to raise $100m through factoring
Intel medicine announces its plans to apply for USD$100 million factoring facility from China Minsheng Bank.
All news and features older than 7 days are subscription only. This article is from the archive. Archived articles could only be accessed with the subscription. If you are a subscriber please log in, alternatively you need to purchase a subscription to view the full content for this page.
